Your browser doesn't support javascript.
loading
Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors.
Chapman, Daniel; Judge, Parminder K; Sardell, Rebecca J; Staplin, Natalie; Arnold, Thomas; Zhu, Doreen; Ng, Sarah; Moffat, Stewart; Landray, Martin J; Baigent, Colin; Hill, Michael; Haynes, Richard; Clark, Sarah; Herrington, William G.
Affiliation
  • Chapman D; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Judge PK; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Sardell RJ; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Staplin N; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Arnold T; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Zhu D; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Ng S; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Moffat S; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Landray MJ; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Baigent C; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Hill M; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Haynes R; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Clark S; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Herrington WG; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: will.her
Kidney Int ; 103(4): 787-790, 2023 04.
Article in En | MEDLINE | ID: mdl-36736537

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Glycosuria Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Kidney Int Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Glycosuria Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Kidney Int Year: 2023 Document type: Article Affiliation country:
...